Literature DB >> 29669218

Making Sense of Triple Inhaled Therapy for COPD.

Samy Suissa1, Jeffrey M Drazen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29669218     DOI： 10.1056/NEJMe1716802

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  [Journal Club].

Authors:  Peter Dovjak
Journal:  Z Gerontol Geriatr       Date:  2018-07       Impact factor: 1.281

Review 2.  Trends and Characteristics of Global Initiative for Chronic Obstructive Lung Disease Guidelines-Discordant Prescribing of Triple Therapy Among Patients with COPD.

Authors:  Surya P Bhatt; Cori Blauer-Peterson; Erin K Buysman; Lindsay G S Bengtson; Swetha R Paine Iii
Journal:  Chronic Obstr Pulm Dis       Date:  2022-04-29

3.  The IMPACT of triple versus dual single-inhaler therapy on exacerbations of COPD.

Authors:  Claudia C Dobler
Journal:  Breathe (Sheff)       Date:  2018-12

4.  Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity.

Authors:  Igor Barjaktarevic; Robert Kaner; Russell G Buhr; Christopher B Cooper
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-23

5.  Real-life effectiveness of indacaterol-glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study.

Authors:  Alan Kaplan; Kenneth R Chapman; Syed M Anees; Irvin Mayers; Driss Rochdi; Michel Djandji; David Préfontaine; Andrew McIvor
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-01-18

Review 6.  Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

Authors:  Lowie Vanfleteren; Leonardo M Fabbri; Alberto Papi; Stefano Petruzzelli; Bartolome Celli
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-12-12

7.  Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review.

Authors:  Sue Langham; Jen Lewis; Nick Pooley; Nina Embleton; Julia Langham; MeiLan K Han; James D Chalmers
Journal:  Respir Res       Date:  2019-11-04

8.  Triple therapy for COPD: a crude analysis from a systematic review of the evidence.

Authors:  Jose Luis Lopez-Campos; Laura Carrasco-Hernandez; Esther Quintana-Gallego; Carmen Calero-Acuña; Eduardo Márquez-Martín; Francisco Ortega-Ruiz; Joan B Soriano
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 9.  Overuse of inhaled corticosteroids in COPD: five questions for withdrawal in daily practice.

Authors:  Didier Cataldo; Eric Derom; Giuseppe Liistro; Eric Marchand; Vincent Ninane; Rudi Peché; Hans Slabbynck; Walter Vincken; Wim Janssens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-07-05

10.  Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study.

Authors:  Gary T Ferguson; Alberto Papi; Antonio Anzueto; Edward M Kerwin; Christy Cappelletti; Elizabeth A Duncan; Jack Nyberg; Paul Dorinsky
Journal:  Eur Respir J       Date:  2018-09-16       Impact factor: 16.671
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.